NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00032175,Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer,https://clinicaltrials.gov/study/NCT00032175,,COMPLETED,"RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if gemcitabine is more effective with or without capecitabine in treating pancreatic cancer.

PURPOSE: Randomized phase III trial to compare the effectiveness of gemcitabine with or without capecitabine in treating patients who have locally advanced or metastatic pancreatic cancer.",NO,Pancreatic Cancer,DRUG: capecitabine|DRUG: gemcitabine hydrochloride,Survival at 1 year,Quality of life|Median survival rate|Survival rate at 2 years|Toxicity|Objective response rate,,Cancer Research UK,,ALL,"ADULT, OLDER_ADULT",PHASE3,508,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT,CRUK-GEM-CAP|CDR0000069263|EU-20116|ISRCTN11513444,2002-04,,2007-05,2003-01-27,,2013-06-26,"Royal United Hospital, Bath, England, BA1 3NG, United Kingdom|Royal Bournemouth Hospital, Bournemouth, England, BH7 7DW, United Kingdom|Bristol Haematology and Oncology Centre, Bristol, England, BS2 8ED, United Kingdom|Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust, Cambridge, England, CB2 2QQ, United Kingdom|Derbyshire Royal Infirmary, Derby, England, DE1 2QY, United Kingdom|Royal Devon and Exeter Hospital, Exeter, England, EX2 5DW, United Kingdom|Ipswich Hospital NHS Trust, Ipswich, England, IP4 5PD, United Kingdom|Queen Elizabeth Hospital, King's Lynn, England, PE30 4ET, United Kingdom|Cookridge Hospital at Leeds Teaching Hospital NHS Trust, Leeds, England, LS16 6QB, United Kingdom|Leicester Royal Infirmary, Leicester, England, LE1 5WW, United Kingdom|Lincoln County Hospital, Lincoln, England, LN2 5QY, United Kingdom|Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, England, L3 9TA, United Kingdom|Royal Liverpool University Hospital, Liverpool, England, L69 3GA, United Kingdom|St. Thomas' Hospital, London, England, SE1 7EH, United Kingdom|Christie Hospital NHS Trust, Manchester, England, M20 4BX, United Kingdom|Clatterbridge Centre for Oncology NHS Trust, Merseyside, England, CH63 4JY, United Kingdom|James Cook University Hospital at South Tees Hospitals NHS Trust, Middlesbrough, Cleveland, England, TS4 3BW, United Kingdom|Northern Centre for Cancer Treatment at Newcastle General Hospital, Newcastle-Upon-Tyne, England, NE4 6BE, United Kingdom|Norfolk and Norwich University Hospital, Norwich, England, NR4 7UY, United Kingdom|Derriford Hospital, Plymouth, England, PL6 8DH, United Kingdom|Poole Hospital NHS Trust, Poole Dorset, England, BH15 2JB, United Kingdom|Whiston Hospital, Prescot Merseyside, England, L35 5DR, United Kingdom|Royal Preston Hospital, Preston, England, PR2 9HT, United Kingdom|Salisbury District Hospital, Salisbury, England, SP2 8BJ, United Kingdom|Royal South Hants Hospital, Southampton, England, SO14 0YG, United Kingdom|University Hospital of North Staffordshire, Stoke-On-Trent, England, ST4 7LN, United Kingdom|Royal Marsden NHS Foundation Trust - Surrey, Sutton, England, SM2 5PT, United Kingdom|Warrington Hospital NHS Trust, Warrington, England, WA5 1QG, United Kingdom|Aberdeen Royal Infirmary, Aberdeen, Scotland, AB25 2ZN, United Kingdom|Singleton Hospital of the Swansea NHS Trust, Swansea, Wales, SA2 8QA, United Kingdom",
